Robert W. Hesslein is EVP, CLO and Secretary of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 7,245 shares of ALNY, which is worth approximately $1.76 Million. The most recent transaction as insider was on Oct 01, 2024, when has been sold 7,245 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.25K
n/a 3M change
n/a 12M change
Total Value Held $1.76 Million

Robert W. Hesslein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2024
BUY
Grant, award, or other acquisition
-
7,245 Added 50.0%
7,245 Common Stock

Also insider at

VYGR
Voyager Therapeutics, Inc. Healthcare
RWH

Robert W. Hesslein

EVP, CLO and Secretary
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Track Activities on ALNY